Cheyne Capital Management (UK)’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,650	Closed	-$473K	–	47
2022 Q4	$473K	Buy	+3,650	New	+$473K	0.83%	40